Last update:

Overweight & Obesity news

Health

Without clean water, Pacific Islanders turn to sugary drinks—tackling this could reduce obesity

One in two people in the Pacific Islands is classified as overweight (with a body mass index of 25–29) or obese (a BMI of 30 or above). This is a problem because obesity increases the risk of health conditions such as diabetes, ...

Health

Subjective walking speed can serve as a simple predictor of metabolic health in obese individuals

Walking speed can provide insights into health, extending beyond mere mobility, so much so that it is considered to be the "sixth vital sign." Past studies have suggested that a slow walking speed is correlated with the development ...

Medications

FDA says shortage of GLP-1 tirzepatide is over

The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss med tirzepatide is over.

Neuroscience

Study finds brain enzyme inhibition reduces obesity in mice

Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers at Université de Montréal's affiliated hospital research center ...

Surgery

Research uncovers key bariatric surgery complication cause

Postprandial hypoglycemia is one of the main complications of bariatric surgery and can affect up to 30% of patients. Unlike ordinary hypoglycemia, in which low blood sugar is usually associated with little food, postprandial ...

Overweight & Obesity

Study links metal levels in urine to childhood obesity risk

Researchers from the Granada Biosanitary Research Institute and the University of Granada have revealed positive and negative associations between exposure to a combination of different metals and overweight and obesity in ...

Overweight & Obesity

Are weight loss drugs like Ozempic, Wegovy safe for kids?

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional—and often ineffective—advice to "eat less and exercise more."

Health

Weight loss brings Americans big health care savings

The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' cost should be covered by Medicare, Medicaid and private insurers.

Overweight & Obesity

Paternal weight associated with baby's size at birth, study finds

A study in Brazil involving 89 father-mother-baby triads points to an association between paternal overweight and newborn birth weight: the higher the father's body mass index (BMI, weight divided by height squared), the ...

Overweight & Obesity

Why some people don't lose weight with Wegovy

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don't work for everyone.

Overweight & Obesity

Study examines California's legislative efforts on obesity

A recent multi-campus study, co-led by public health researchers from UC Irvine and UC Merced, published in the journal BMC Public Health is the first of its kind to examine California's legislative approaches to prevent ...

Health

Clinical study supports the anti-obesity effects of kimchi

Approximately 16% of the global population, or about 890 million people, suffer from obesity. The World Health Organization (WHO) has recognized obesity as a significant health issue and highlighted its impact on the quality ...